We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Clorox (CLX) Gains 35% in 6 Months: Will the Rally Continue?
Read MoreHide Full Article
The Clorox Company (CLX - Free Report) is performing exceedingly well on the back of smooth execution of its 2020 plans, expansion of e-commerce capabilities and Go Lean strategy. Also, the company is benefiting from strategic acquisitions and product innovations. This, in turn, is leading to higher volumes, thus boosting the top line.
The company boasts a robust earnings surprise history, having surpassed estimates for the eighth straight quarter, when it reported first-quarter fiscal 2019 results. Moreover, sales exceeded estimates in four of the trailing six quarters. Both the top and bottom line in the quarter also improved year over year. While earnings benefited from a lower tax rate along with higher sales and gains from cost savings, sales were driven by benefits of the Nutranext acquisition besides higher volumes and increased prices.
Despite a solid start in fiscal 2019, Clorox trimmed its earnings guidance for the fiscal year. Management anticipates earnings from continuing operations to be in the range of $6.20-$6.40 per share, down from $6.32-$6.52 projected previously. This guidance was slashed mainly due to the expectations of making fewer share repurchases in fiscal 2019 than nearly 50% of its $2-billion share repurchase authorization guided earlier. Also, adverse impacts from foreign currency and higher costs negatively impacted earnings forecast. Moreover, elevated commodity and logistics expenses are hurting gross margins.
Nevertheless, shares of Clorox have surged 34.7% in the past six months, outperforming the industry’s 12.9% rally. Impressive earnings history and strategic efforts led to this outperformance. Also, the company’s expected long-term earnings growth rate of 6.5% with a Growth Score of A drives optimism on the stock.
Let’s Take a Look at Clorox’s Strategic Efforts
Clorox’s 2020 Strategy is focused on boosting growth at various categories and expanding overall market share. Also, it is aimed at achieving certain long-term aspirations, including net sales growth of 3-5%, increasing EBIT margin by 25-50 basis points and generating free cash flow of 10-12% of sales, all on a yearly basis. This is expected to be achieved through key accelerators like investment in brands; development of e-commerce; technological advancements; enhancement of growth culture and focus on the 3Ds - desire, decision and delight.
Additionally, Clorox is keen on making strategic partnerships with retail customers and evolving capabilities both offline and online. Over the past few years, the company has boosted its digital capabilities leading to a strong performance in e-commerce, which is now a significant revenue contributor. Moving ahead, the company is well on track to attain its 2020 target of $500 million from e-commerce sales.
Clorox's diversified brand portfolio along with its Go Lean strategy is encouraging as well. The company remains committed toward investing in product and brand differentiation to safeguard value proposition. Backed by the Go Lean strategy, Clorox is consistently making efforts to improve margins through operational efficiencies and improving productivity.
We believe all these strategies will help the company to overcome near-term challenges and continue with its upside run on the index.
Currently, Clorox has a Zacks Rank #3 (Hold).
Interested in Consumer Staples Stocks? Check These
Archer Daniels Midland Company (ADM - Free Report) delivered an average positive earnings surprise of 26.9% in the trailing four quarters. The company carries a Zacks Rank #2 (Buy).
Church & Dwight Co., Inc. (CHD - Free Report) is also a Zacks Ranked #2 stock, which has an expected long-term earnings growth rate of 10.1%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Clorox (CLX) Gains 35% in 6 Months: Will the Rally Continue?
The Clorox Company (CLX - Free Report) is performing exceedingly well on the back of smooth execution of its 2020 plans, expansion of e-commerce capabilities and Go Lean strategy. Also, the company is benefiting from strategic acquisitions and product innovations. This, in turn, is leading to higher volumes, thus boosting the top line.
The company boasts a robust earnings surprise history, having surpassed estimates for the eighth straight quarter, when it reported first-quarter fiscal 2019 results. Moreover, sales exceeded estimates in four of the trailing six quarters. Both the top and bottom line in the quarter also improved year over year. While earnings benefited from a lower tax rate along with higher sales and gains from cost savings, sales were driven by benefits of the Nutranext acquisition besides higher volumes and increased prices.
Despite a solid start in fiscal 2019, Clorox trimmed its earnings guidance for the fiscal year. Management anticipates earnings from continuing operations to be in the range of $6.20-$6.40 per share, down from $6.32-$6.52 projected previously. This guidance was slashed mainly due to the expectations of making fewer share repurchases in fiscal 2019 than nearly 50% of its $2-billion share repurchase authorization guided earlier. Also, adverse impacts from foreign currency and higher costs negatively impacted earnings forecast. Moreover, elevated commodity and logistics expenses are hurting gross margins.
Nevertheless, shares of Clorox have surged 34.7% in the past six months, outperforming the industry’s 12.9% rally. Impressive earnings history and strategic efforts led to this outperformance. Also, the company’s expected long-term earnings growth rate of 6.5% with a Growth Score of A drives optimism on the stock.
Let’s Take a Look at Clorox’s Strategic Efforts
Clorox’s 2020 Strategy is focused on boosting growth at various categories and expanding overall market share. Also, it is aimed at achieving certain long-term aspirations, including net sales growth of 3-5%, increasing EBIT margin by 25-50 basis points and generating free cash flow of 10-12% of sales, all on a yearly basis. This is expected to be achieved through key accelerators like investment in brands; development of e-commerce; technological advancements; enhancement of growth culture and focus on the 3Ds - desire, decision and delight.
Additionally, Clorox is keen on making strategic partnerships with retail customers and evolving capabilities both offline and online. Over the past few years, the company has boosted its digital capabilities leading to a strong performance in e-commerce, which is now a significant revenue contributor. Moving ahead, the company is well on track to attain its 2020 target of $500 million from e-commerce sales.
Clorox's diversified brand portfolio along with its Go Lean strategy is encouraging as well. The company remains committed toward investing in product and brand differentiation to safeguard value proposition. Backed by the Go Lean strategy, Clorox is consistently making efforts to improve margins through operational efficiencies and improving productivity.
We believe all these strategies will help the company to overcome near-term challenges and continue with its upside run on the index.
Currently, Clorox has a Zacks Rank #3 (Hold).
Interested in Consumer Staples Stocks? Check These
The Chefs' Warehouse, Inc. (CHEF - Free Report) has an impressive long-term earnings growth rate of 19% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Archer Daniels Midland Company (ADM - Free Report) delivered an average positive earnings surprise of 26.9% in the trailing four quarters. The company carries a Zacks Rank #2 (Buy).
Church & Dwight Co., Inc. (CHD - Free Report) is also a Zacks Ranked #2 stock, which has an expected long-term earnings growth rate of 10.1%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>